The oculocerebrorenal syndrome, also known as Lowe syndrome, was first described by Lowe et al. in 1952. It is a rare, X-linked recessive multisystem disorder that classically presents with a triad of congenital cataracts, renal failure, and intellectual delay. The causative OCRL gene encodes an enzyme involved in a number of intracellular processes. Researchers have elucidated a broad spectrum of phenotypic features linked to mutations in OCRL. This activity reviews the epidemiology, clinical features, and management of oculocerebrorenal syndrome. Additionally, it highlights the importance of an interprofessional team in caring for patients with this disorder.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/140257
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.5 Point; Credit Type(s): Lifelong Learning (ABA)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Ambulatory/Outpatient, Dermatopathology, Developmental-Behavioral Pediatrics, General Pediatrics, General Surgery, Hospital Medicine, Molecular Genetic Pathology, Neonatal-Perinatal Medicine, Neurodevelopmental Disabilities, Pediatric Anesthesia, Pediatric Endocrinology, Pediatric Nephrology, Pediatric Neurology
Subscribe
Login
0 Comments
Oldest